Abstract In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee
began the process of a complete update of recommendations for early prostate cancer …

At present, only three risk factors for prostate cancer have been firmly established; these are
all nonmodifiable: age, race, and a positive family history of prostate cancer. However …

Prostate cancer is a significant public health burden and a major cause of morbidity and
mortality among men worldwide. Analyzing geographic patterns and temporal trends may …

The ability to diagnose the early onset of disease, rapidly, non-invasively and unequivocally
has multiple benefits. These include the early intervention of therapeutic strategies leading …

ContextThe United States spends considerably more money on health care than the United
Kingdom, but whether that translates to better health outcomes is unknown. ObjectiveTo …

Prostate cancer incidence and mortality in most native Asian populations have gradually
increased, but are around one-third lower than in corresponding Asian–American cohorts …

After 20 years of screening for breast and prostate cancer, several observations can be
made. First, the incidence of these cancers increased after the introduction of screening but …

This review outlines current international patterns in prostate cancer incidence and mortality
rates and survival, including recent trends and a discussion of the possible impact of …

ContextThree fourths of US men older than 50 years have been screened with prostate-
specific antigen (PSA) for prostate cancer. ObjectiveTo estimate the receiver operating …

Abstract Background: The American Cancer Society, the Centers for Disease Control and
Prevention (CDC), the National Cancer Institute (NCI), and the North American Association …